Literature DB >> 20732812

3D-QSAR CoMFA study of benzoxazepine derivatives as mGluR5 positive allosteric modulators.

Edward W Lowe1, Alysia Ferrebee, Alice L Rodriguez, P Jeffrey Conn, Jens Meiler.   

Abstract

Positive allosteric modulation of the metabotropic glutamate receptor subtype 5 was studied by conducting a comparative molecular field analysis on 118 benzoxazepine derivatives. The model with the best predictive ability retained significant cross-validated correlation coefficients of q(2) = 0.58 (r(2) = 0.81) yielding a standard error of 0.20 in pEC(50) for this class of compounds. The subsequent contour maps highlight the structural features pertinent to the bioactivity values of benzoxazepines.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732812      PMCID: PMC2943337          DOI: 10.1016/j.bmcl.2010.07.061

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

Review 1.  Metabotropic glutamate receptors: electrical and chemical signaling properties.

Authors:  Victoria Coutinho; Thomas Knöpfel
Journal:  Neuroscientist       Date:  2002-12       Impact factor: 7.519

Review 2.  Direct and indirect modulation of the N-methyl D-aspartate receptor.

Authors:  M J Marino; P Jeffrey Conn
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2002-02

3.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

Authors:  R D Cramer; D E Patterson; J D Bunce
Journal:  J Am Chem Soc       Date:  1988-08-01       Impact factor: 15.419

Review 4.  Glutamatergic mechanisms in schizophrenia.

Authors:  Guochuan Tsai; Joseph T Coyle
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

Review 5.  Metabotropic glutamate receptors: electrophysiological properties and role in plasticity.

Authors:  R Anwyl
Journal:  Brain Res Brain Res Rev       Date:  1999-01

Review 6.  Pharmacology and functions of metabotropic glutamate receptors.

Authors:  P J Conn; J P Pin
Journal:  Annu Rev Pharmacol Toxicol       Date:  1997       Impact factor: 13.820

7.  Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA.

Authors:  B L Bush; R B Nachbar
Journal:  J Comput Aided Mol Des       Date:  1993-10       Impact factor: 3.686

8.  Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening.

Authors:  Ralf Mueller; Alice L Rodriguez; Eric S Dawson; Mariusz Butkiewicz; Thuy T Nguyen; Stephen Oleszkiewicz; Annalen Bleckmann; C David Weaver; Craig W Lindsley; P Jeffrey Conn; Jens Meiler
Journal:  ACS Chem Neurosci       Date:  2010-01-28       Impact factor: 4.418

Review 9.  Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia.

Authors:  Bita Moghaddam
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

Review 10.  Ionotropic glutamate receptors as therapeutic targets in schizophrenia.

Authors:  Joseph T Coyle; Guochuan Tsai; Donald C Goff
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2002-04
View more
  2 in total

1.  Immunomodulatory effects of 1-(6-hydroxy-2-isopropenyl-1-benzofuran-5-yl)-1-ethanone from Petasites hybridus and its synthesized benzoxazepine derivatives.

Authors:  Fatemeh Khaleghi; Ibrahim Jantan; Laily Bin Din; Wan A Yaacob; Mohammad A Khalilzadeh; Syed Nasir Abbas Bukhari
Journal:  J Nat Med       Date:  2013-10-24       Impact factor: 2.343

2.  General Purpose Structure-Based Drug Discovery Neural Network Score Functions with Human-Interpretable Pharmacophore Maps.

Authors:  Benjamin P Brown; Jeffrey Mendenhall; Alexander R Geanes; Jens Meiler
Journal:  J Chem Inf Model       Date:  2021-01-26       Impact factor: 4.956

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.